ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Kowa Pharmaceuticals America, INC.

Official 2024 U.S. DOL Form 5500 summary for Kowa Pharmaceuticals America, INC. (Kowa Pharmaceuticals America, INC. 401(k) Plan · EIN 20-1414357 · PN 001): $37.53M net assets, 215 active participants, and $15.22 per $10,000 (15.22 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorKowa Pharmaceuticals America, INC.
Filing IdentifierKowa Pharmaceuticals America, INC. 401(k) Plan · EIN 20-1414357 · PN 001
Plan Category & State401(k) Defined Contribution (AL)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$37.53M
Active Participants215
Direct Admin Fee Rate$15.22 per $10,000 (15.22 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderWarren Averett, LLC
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI